spacer
home > ict > winter 2018 > proms in practise
PUBLICATIONS
International Clinical Trials

PROMs in Practise

As life expectancy rises and clinical investigations and treatments get ever more effective and complex, expectations of what health systems should deliver in terms of keeping people healthy for longer are, rightly, growing. However, the longstanding challenges of wide variation in access and quality, even within a single system, and spiralling costs are putting an ever greater strain on health systems and pose a risk to continued progress.

Today, healthcare quality is mainly understood in terms of process measures, such as waiting times, length of stay, and discharge rates as well as the unintended consequences or complications of care, such as hospital acquired infections and mortality. These measures are clearly important and need to be measured and managed, but they do not help patients or clinicians understand the actual results of care from the perspective of the patient. This includes information about which patients get better or worse or in what circumstances treatment is successful, whether it is generally done at the right time by a particular doctor or hospital and, if not, why not, how long the benefits last or the relative successes between treatments, doctors, and hospitals. The International Consortium of Health Outcomes Measurement (ICHOM) define ‘outcomes’ as: “The results people care about most when seeking treatment, including functional improvement and the ability to live normal, productive lives” (1). ICHOM was established in 2014 as a partnership between Harvard Business School, Boston Consulting Group, and the Karolinska Institutet in Sweden to set a global standard for outcomes measurement at the level of the clinical condition.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
As life expectancy rises and clinical investigations and treatments get ever more effective and complex, expectations of what health systems should deliver in terms of keeping people healthy for longer are, rightly, growing. However, the longstanding challenges of wide variation in access and quality, even within a single system, and spiralling costs are putting an ever greater strain on health systems and pose a risk to continued progress.

Today, healthcare quality is mainly understood in terms of process measures, such as waiting times, length of stay, and discharge rates as well as the unintended consequences or complications of care, such as hospital acquired infections and mortality. These measures are clearly important and need to be measured and managed, but they do not help patients or clinicians understand the actual results of care from the perspective of the patient. This includes information about which patients get better or worse or in what circumstances treatment is successful, whether it is generally done at the right time by a particular doctor or hospital and, if not, why not, how long the benefits last or the relative successes between treatments, doctors, and hospitals. The International Consortium of Health Outcomes Measurement (ICHOM) define ‘outcomes’ as: “The results people care about most when seeking treatment, including functional improvement and the ability to live normal, productive lives” (1). ICHOM was established in 2014 as a partnership between Harvard Business School, Boston Consulting Group, and the Karolinska Institutet in Sweden to set a global standard for outcomes measurement at the level of the clinical condition.
spacer
Dr Tim Williams
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Genome & Company Chooses Luina Bio to Supply Innovative Drug Productfor Clinical Trials Programme

Luina Bio, a leading biopharmaceutical manufacturing company in Australia, today announced it will develop and produce an innovative bacterial drug product for Genome & Company to support its clinical trials programme. The relationship signals Luina Bio’s first foray into Asia and further establishes its global leadership in the current Good Manufacturing Practise for microbiome projects.
More info >>

White Papers
 
Industry Events

PDA Europe Annual Meeting 2019

24 June 2019, Hilton Amsterdam

Featuring updates from international regulatory agencies as well as industry, this promises to become another highlight in the 2019 event calendar and is a meeting not to be missed!
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement